Content about House Speaker

March 21, 2011
GPhA responds to potential OGD funding cuts; announces exit of Gordon Johnston

The generic drug industry’s main lobby in Washington is hoping to head off cuts to the Food and Drug Administration’s Office of Generic Drugs, which it said could have a “devastating impact” on those who rely on generics.

WASHINGTON — The generic drug industry’s main lobby in Washington is hoping to head off cuts to the Food and Drug Administration’s Office of Generic Drugs, which it said could have a “devastating impact” on those who rely on generics.

Republicans in Congress have sought to reduce government spending by making large cuts to various domestic programs and agencies, including the FDA, which critics of the plan said could jeopardize food and drug safety.

September 21, 2010
New Health Reform Report website provides 'real facts, trusted analysis' about healthcare law

Newt Gingrich, former House speaker and founder of the Center for Health Transformation, unveiled a...

WASHINGTON Newt Gingrich, former House speaker and founder of the Center for Health Transformation, unveiled a new website on Wednesday -- HealthReformReport.com -- dedicated to providing “real facts, trusted analysis” with news about how the new federal healthcare law impacts individuals, doctors, businesses, hospitals, insurers and others.

December 17, 2009
Pharmacy groups hail bipartisan effort to lift Medicaid generic dispensing rates

A small group of U.S. representatives from both parties has asked House Speaker Nancy Pelosi...

NEW YORK A small group of U.S. representatives from both parties has asked House Speaker Nancy Pelosi for changes in health-reform legislation that would boost payment rates to hard-pressed pharmacies when dispensing generic drugs to Medicaid patients.

 

November 12, 2009
Independents’ lobby urges changes to health-reform bill passed in House

Like their chain pharmacy counterparts, the people who own and operate their own single-store or...

NEW YORK Like their chain pharmacy counterparts, the people who own and operate their own single-store or small-chain drug stores — as well as the advocacy groups that lobby on their behalf — are keeping close tabs on the progress of the various health-reform bills moving through the U.S. Senate and House. They should.